Loading

opioids

  • by Kevin Mahmalji, NORML Outreach Director August 31, 2018

    In recognition of International Overdose Awareness Day, NORML chapters around the country are taking action to highlight the positive that marijuana legalization can play in combating America’s opioid crisis. Many NORML leaders are hosting community forums to highlight the growing evidence that regulated marijuana access is positively associated with decrease in opioid overdose fatalities, hospitalizations, dependency and use.

    To amplify these efforts, NORML has created action alerts targeting local, state, and federal opioid task forces and committees — urging them to make marijuana regulation a part of their discussions and strategies.

    Please take just two minutes to use our prewritten letters and send a message to each target.

    The Office of National Drug Control Policy: Contact the ONDCP Commission: Medical Marijuana as an Alternative to Opioids

    Federal lawmakers: Urge your members of Congress to acknowledge the role of cannabis in combating the prescription drug overdose epidemic

    State lawmakers: Urge your state lawmakers to acknowledge the role of cannabis in combating the prescription drug overdose epidemic

    Opioid-involved overdose deaths have increased five-fold since 1999 and were involved in over 40,000 deaths in 2016. Deaths involving benzodiazepines, a family of anti-anxiety drugs, have increased eight-fold during this same time period.

    Several observational studies — such as those here, here, and here — find that medical marijuana regulation is correlated with reductions in opioid-related use, drug spending, abuse, hospitalization, and mortality. Separate data evaluating prescription drug use trends among individual patients enrolled in state-licensed medical marijuana programs is consistent with this conclusion, finding that many chronic pain subjects reduce or eliminate their use of opioids following enrollment.

    The available data is consistent and clear. For many patients, cannabis offers a viable alternative to opioids. It is time for lawmakers to stop placing political ideology above the health and safety of the American public, and to acknowledge the safety and efficacy of marijuana as an alternative medical treatment.

    You can review many more published studies on the NORML factsheet Relationship Between Marijuana and Opioids.

    Help us raise awareness by using our Social Media Tools below:

    Click here to share on Facebook
    Click here to share on Twitter
    Click here to share on Instagram

    Is there an active opioid commission or task force in your community? Email me at KevinM@NORML.org and we’ll create an action alert to engage and educate your elected officials about the role access to marijuana can play in reducing opioid-related deaths, hospitalizations, and total number of opioids prescribed.

     

     

     

  • by Kevin Mahmalji, NORML Outreach Director August 14, 2018

    Due to growing concerns about the impact America’s opioid crisis is having on his state, Nevada Governor Brian Sandoval along with Governors Steve Bullock of Montana, Charlie Backer of Massachusetts, and Kate Brown of Oregon, recently sent a letter to federal lawmakers requesting support for state and local-level initiatives:

    “Every day governors face the devastating impact of this disease on our communities, health care system, schools and families,” the letter reads. “Governors need increased financial and technical support to address this crisis and we urge Congress to avoid burdensome requirements on state programs.”

    Read more here: https://www.nga.org/wp-content/uploads/2018/07/NGA-Letter-6.7.2018.pdf

    In addition to his formal request for Congressional support, Governor Sandoval created the Governor’s Opioid State Action Accountability Task Force to explore, among other things, education and guidelines for treatment options and data collection.

    Click here to urge the Governor’s Opioid State Action Accountability Task Force to acknowledge the role that marijuana can play in combating Nevada’s opioid epidemic

    When asked about the Governor’s actions, Executive Director of Nevada NORML Madisen Saglibene had this to say: “State data shows that per 100,000 patients, Nevada ranks 2nd highest for hydrocodone and oxycontin addiction in the nation. Furthermore, Las Vegas ranked 4th highest in the nation for methadone, and 7th for codeine. So while we appreciate the efforts of Governor Sandoval, we’re encouraging members the the Governor’s Task Force to consider the positive role access to marijuana can play in addressing this issue.”

    Several observational studies – such as those here, here, and here – find that medical marijuana regulation is correlated with reductions in opioid-related use, drug spending, abuse, hospitalization, and mortality. Separate data evaluating prescription drug use trends among individual patients enrolled in state-licensed medical marijuana programs is consistent with this conclusion, finding that many chronic pain subjects reduce or eliminate their use of opioids following enrollment.

    Nevada lawmakers should not ignore the reality that access to marijuana can play a role in mitigating the opioid abuse crisis. Use NORML’s online action center below to urge members of the Governor’s Opioid State Action Accountability Task Force to acknowledge the positive role that access to marijuana is playing in combating the prescription drug overdose epidemic, and promoting greater public health and safety.

    Click here to urge the Governor’s Opioid State Action Accountability Task Force to acknowledge the role that marijuana can play in combating Nevada’s opioid epidemic

    Is there an active opioid commission or task force in your community? Email KevinM@NORML.org and we’ll create an action alert to engage and educate your elected officials about the role access to marijuana can play in reducing opioid-related deaths, hospitalizations, and total number of opioids prescribed.

  • by Kevin Mahmalji, NORML Outreach Director August 7, 2018

    With six meetings scheduled before next year’s legislative session, members of Colorado’s Opioid and Other Substance Use Disorders Study Committee are working diligently to address an issue many local and state governments are currently struggling with across America. As the total number of opioid-related deaths continues to grow beyond the more than 40,000 deaths that were reported in 2016, lawmakers are willing to consider all options.

    Click here to urge Colorado’s Opioid and Other Substance Use Disorders Study Committee to acknowledge the role that marijuana can play in combating Colorado’s opioid epidemic

    The committee was established earlier this year with the passage of House Bill 18-1003 to explore what other states are doing to address substance use disorders, explore harm reduction, treatment, and recovery option, and of course identify possible legislative solutions.

    “Among other initiatives, the committee will study data and statistics on the scope of the substance use disorder problem in the state, study current prevention, intervention, harm reduction, treatment and recovery resources available to citizens, as well as public and private insurance coverage and other sources of support for treatment and recovery resources and examine measures other states and countries use to address substance use disorders.”

    Read more from The Pueblo Chieftain

    Several observational studies – such as those here, here, and here – find that medical marijuana regulation is correlated with reductions in opioid-related use, drug spending, abuse, hospitalization, and mortality. Separate data evaluating prescription drug use trends among individual patients enrolled in state-licensed medical marijuana programs is consistent with this conclusion, finding that many chronic pain subjects reduce or eliminate their use of opioids following enrollment. Colorado lawmakers should not ignore the reality that access to marijuana can play a role in mitigating the opioid abuse crisis.

    Click here to urge Colorado’s Opioid and Other Substance Use Disorders Study Committee to acknowledge the role that marijuana can play in combating Colorado’s opioid epidemic

    Is there an active opioid commission or task force in your community? Email KevinM@NORML.org and we’ll create an action alert to engage and educate your elected officials about the role marijuana can play in reducing opioid-related deaths, hospitalizations, and total number of opioids prescribed.

     

  • by Paul Armentano, NORML Deputy Director July 11, 2018

    The enactment of medical cannabis access laws is associated with significant reductions in prescription opioid use among Medicaid enrollees, according to just-published data in the journal Addiction.

    Investigators with the University of California at San Diego assessed the relationship between medical cannabis legalization and opioid use among Medicaid enrollees over a period of 21 years (1993 to 2014).

    Authors reported, “For Schedule III opioid prescriptions, medical cannabis legalization was associated with a 29.6 percent reduction in number of prescriptions, 29.9 percent reduction in dosage, and 28.8 percent reduction in related Medicaid spending.” This correlation remained after authors controlled for potential confounders, such as the establishment of prescription drug monitoring programs and variations in patients’ income.

    By contrast, authors did not report similar changes in enrollees’ use of Schedule II opioid drugs, like Oxycodone. Authors speculated that this result may be because physicians are more reticent to recommend medical cannabis options to these patients.

    They concluded: “In this study, we found that statewide medical cannabis legalization implemented in 1993-2014 in the US was associated with close to 30 percent reductions in Schedule III opioids received by Medicaid enrollees.. … It was estimated that, if all the states had legalized medical cannabis by 2014, Medicaid annual spending on opioid prescriptions would be reduced by 17.8 million dollars.”

    Their findings are similar to those of numerous other observational studies – such as those here, here, and here – finding that medical marijuana regulation is correlated with reductions in overall opioid-related use, drug spending, abuse, hospitalization, and mortality. Separate data evaluating prescription drug use trends among individual patients enrolled in state-licensed medical marijuana programs is consistent with this conclusion, finding that many subjects reduce or eliminate their use of opioids following enrollment.

    The abstract of the new study, “Medical cannabis legalization and opioid prescriptions: Evidence of US Medicaid enrollees during 1993-2014,” appears online here.

  • by NORML June 22, 2018

    KY NORML is passionate about education. And with the opioid epidemic consuming our state, we feel that it is our duty to share valuable information regarding the relationship between cannabis and opioids. Cannabis access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, traffic fatalities, drug treatment admissions, and overdose deaths. We strongly believe, based on research, first-hand accounts, and testimonials that cannabis is truly the answer to combating this crisis that is killing thousands of Kentuckians each year.

    According to a study by the Journal of Headache and Pain, “the most common prescription medications replaced by medicinal cannabis in this study were opiates/opioids in a large percentage within every pain group, up to 72.8% of patients in the chronic pain as primary illness group. … This is notable given the well-described “opioid-sparing effect” of cannabinoids and growing abundance of literature suggesting that cannabis may help in weaning from these medications and perhaps providing a means of combating the opioid epidemic.”

    Investigators assessed opioid use patterns in patients registered with Health Canada to access medical cannabis products. Among those patients who acknowledged using opioids upon enrollment in the trial, 51 percent reported ceasing their opiate use within six-months. “The high rate of cannabis use for the treatment of chronic pain — and subsequent substitution for opioids — suggests that cannabis may play a harm-reduction role in the ongoing opioid dependence and overdose crisis. While the cannabis substitution effect for prescription drugs has been identified and assessed via cross-sectional and population-level research, this study provides a granular individual-level perspective of cannabis substitution for prescription drugs and associated improvement in quality of life over time.”

    Cannabis access is associated with reductions in overall prescription drug spending. JAMA Internal Medicine “found that prescriptions filled for all opioids decreased by 2.11 million daily doses per year from an average of 23.08 million daily doses per year when a state instituted any medical cannabis law. Prescriptions for all opioids decreased by 3.742 million daily doses per year when medical cannabis dispensaries opened. … Combined with previously published studies suggesting cannabis laws are associated with lower opioid mortality, these findings further strengthen arguments in favor of considering medical applications of cannabis as one tool in the policy arsenal that can be used to diminish the harm of prescription opioids.”

    The Mental Health Clinician  “investigated medical cannabis’ effectiveness in patients suffering from chronic pain associated with qualifying conditions for MC in New York State. … After 3 months treatment, MC improved quality of life, reduced pain and opioid use, and lead to cost savings. … These results are consistent with previous reports demonstrating MC’s effectiveness in neuropathic pain.”

    There are tons more information out there on this topic and the above research barely scratches the surface. We encourage you to see what’s out there for yourself. Knowledge is power and the better armed we are with that knowledge the more effective we can be in getting legislation passed. The opioid crisis that is plaguing our state has harmed so many of our citizens, and if cannabis is able to help, the legislators should get out the way and pass a comprehensive bill to deal with the problems our state is facing.

    High Regards,
    Matthew Bratcher
    Executive Director, KY NORML

    To support KY NORML you can DONATE HERE and follow us on Facebook and Twitter! Your donations help pay the bills and allow us to function and continue to make a difference in our state! Can you kick in $5, $10 or $20 to help us keep going?

Page 1 of 712345...Last »